Trending:
Eli Lilly & Co. (LLY) Stock News, Earnings & History
(NYSE:LLY) Healthcare
Enjoy Interactive Tools and Indicators
52wk high:
58.40
52wk low:
39.93
EPS:
4.16
P/E:
13.16
Div Rate:
1.96
Yield:
3.50
Market Cap:
59.34B
Avg Vol (3m):
5.07M
Latest Headlines
Insider Trading Cheat Sheet
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | May 15 | Sale | 56.15 | 5,000 | 280,750 | 72,177 | May 16 04:06 PM |
| Simmons Jeffrey N | SVP&Pres.,Elanco Animal Health | May 10 | Sale | 54.49 | 10,000 | 544,900 | 51,750 | May 13 03:37 PM |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | May 01 | Option Exercise | 0.00 | 10,000 | 0 | 81,875 | May 01 03:46 PM |
| Simmons Jeffrey N | SVP&Pres.,Elanco Animal Health | May 01 | Option Exercise | 0.00 | 10,000 | 0 | 66,385 | May 01 03:44 PM |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | Apr 15 | Sale | 57.10 | 5,000 | 285,500 | 71,875 | Apr 16 11:46 AM |
| Mahony Susan | SVP & Pres., Lilly Oncology | Mar 26 | Sale | 56.00 | 5,000 | 280,000 | 47,380 | Mar 26 01:03 PM |
| Lundberg Jan M | EVP,Science&Tech and Pres. LRL | Mar 12 | Sale | 55.38 | 19,000 | 1,052,220 | 100,253 | Mar 13 11:21 AM |
| Ricks David A | SVP and Pres, Lilly Bio-Meds | Feb 08 | Sale | 53.91 | 3,000 | 161,730 | 26,941 | Feb 11 03:59 PM |
| Rice Derica W | EVP-Global Services and CFO | Feb 05 | Sale | 54.21 | 29,646 | 1,607,110 | 52,605 | Feb 07 09:29 AM |
| Mahony Susan | SVP & Pres., Lilly Oncology | Feb 01 | Option Exercise | 0.00 | 22,943 | 0 | 57,380 | Feb 04 04:27 PM |
| Lundberg Jan M | EVP,Science&Tech and Pres. LRL | Feb 01 | Option Exercise | 0.00 | 77,456 | 0 | 134,910 | Feb 04 04:26 PM |
| LECHLEITER JOHN C | Chairman, President, and CEO | Feb 01 | Option Exercise | 0.00 | 132,367 | 0 | 529,223 | Feb 04 04:25 PM |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | Feb 01 | Option Exercise | 0.00 | 31,768 | 0 | 91,797 | Feb 04 04:23 PM |
| Tapiero Jacques | SVP&Pres., Emerging Markets | Feb 01 | Option Exercise | 0.00 | 17,649 | 0 | 48,983 | Feb 04 04:33 PM |
| Simmons Jeffrey N | SVP&Pres.,Elanco Animal Health | Feb 01 | Option Exercise | 0.00 | 17,649 | 0 | 64,566 | Feb 04 04:31 PM |
Fundamental Cheat Sheet
| Index | S&P 500 | P/E | 13.13 | EPS (ttm) | 4.17 | Insider Own | 0.13% | Shs Outstand | 1.13B | Perf Week | -2.15% |
| Market Cap | 61.67B | Forward P/E | 20.05 | EPS next Y | 2.73 | Insider Trans | 60.14% | Shs Float | 1.12B | Perf Month | -1.48% |
| Income | 4.63B | PEG | - | EPS next Q | 1.00 | Inst Own | 74.36% | Short Float | 1.29% | Perf Quarter | 1.75% |
| Sales | 22.60B | P/S | 2.73 | EPS this Y | -6.24% | Inst Trans | -1.38% | Short Ratio | 2.85 | Perf Half Y | 18.10% |
| Book/sh | 13.26 | P/B | 4.13 | EPS next Y | -30.18% | ROA | 14.33% | Target Price | 56.41 | Perf Year | 40.14% |
| Cash/sh | 4.20 | P/C | 13.03 | EPS next 5Y | -2.00% | ROE | 31.06% | 52W Range | 38.39 - 57.89 | Perf YTD | 12.98% |
| Dividend | 1.96 | P/FCF | 38.87 | EPS past 5Y | 6.21% | ROI | 18.36% | 52W High | -5.44% | Beta | 0.72 |
| Dividend % | 3.58% | Quick Ratio | 1.28 | Sales past 5Y | 3.94% | Gross Margin | 78.95% | 52W Low | 42.59% | ATR | 0.97 |
| Employees | 38100 | Current Ratio | 1.62 | Sales Q/Q | 0.00% | Oper. Margin | 26.65% | RSI (14) | 45.39 | Volatility | 1.79% 1.62% |
| Optionable | Yes | Debt/Eq | 0.37 | EPS Q/Q | 56.62% | Profit Margin | 20.46% | Rel Volume | 0.76 | Prev Close | 54.92 |
| Shortable | Yes | LT Debt/Eq | 0.30 | Earnings | Apr 24 BMO | Payout | 48.64% | Avg Volume | 5.09M | Price | 54.74 |
| Recom | 2.60 | SMA20 | -0.50% | SMA50 | -1.48% | SMA200 | 8.98% | Volume | 3,872,572 | Change | -0.33% |
* The data is daily updated on 5:30PM EST
Wall St. Cheat Sheet has been featured in these fine media outlets:
